Related Experiment Video
Updated: Aug 17, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
The role of calcium antagonists in patients with chronic renal failure
1University of Münster Medical School, c/o Potstiege 42, 48161 Münster, Germany. rahn@uni-muenster.de
Insights
For patients with chronic renal failure and high blood pressure, initiating treatment with renin-angiotensin system inhibitors is recommended. These drugs are more effective than calcium antagonists in slowing kidney function decline.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hypertension is common in chronic renal failure (CRF) and increases cardiovascular risk.
- Antihypertensive therapy aims to reduce cardiovascular events and slow kidney disease progression.
- Calcium antagonists are established antihypertensives but may not be optimal for CRF.
Purpose of the Study:
- To evaluate the efficacy of different antihypertensive drug classes in patients with chronic renal failure.
- To determine the optimal initial pharmacotherapy for hypertensive patients with CRF.
Main Methods:
- Review of numerous studies and controlled clinical trials.
- Comparative analysis of antihypertensive agents, including calcium antagonists and renin-angiotensin system inhibitors.
- Focus on outcomes related to cardiovascular events and renal function preservation.
Main Results:
- Calcium antagonists effectively lower blood pressure and prevent cardiovascular complications, similar to other classes.
- Drugs targeting the renin-angiotensin system (ACE-inhibitors and AT1-antagonists) demonstrate superior efficacy in delaying renal insufficiency progression in CRF patients.
- ACE-inhibitors and AT1-antagonists show particular benefit in patients with type-2 diabetic nephropathy.
Conclusions:
- While calcium antagonists are safe and effective for blood pressure control, they are not superior in preventing cardiovascular complications.
- Renin-angiotensin system inhibitors are more beneficial than other antihypertensive agents for patients with chronic renal failure.
- Initial antihypertensive treatment for hypertensive patients with CRF should involve a drug that inhibits the renin-angiotensin system.
Abstract:
The objective of antihypertensive treatment in patients with chronic renal failure, many of whom have elevated blood pressure levels, is to reduce cardiovascular events and to slow down the progression of kidney function impairment. Calcium antagonists have been shown to be effective and safe antihypertensive drugs in patients from different age groups, including children. On the basis of numerous studies, one may conclude that the main benefit of antihypertensive therapy is because of the blood pressure lowering effect per se and that calcium antagonists do not differ from other antihypertensive drugs in the ability to prevent cardiovascular complications of hypertension. In particular, calcium antagonists are not inferior to other groups of antihypertensive agents in the prevention of coronary artery disease. There is, however, now evidence from controlled clinical trials that drugs interfering with the renin-angiotensin system are more beneficial than other antihypertensive agents in patients with chronic renal failure. Thus, several studies have demonstrated that ACE-inhibitors and, in patients with type-2 diabetic nephropathy, AT 1-antagonists are superior to other classes of antihypertensive drugs, including calcium antagonists, in delaying the progression of renal insufficiency. Therefore, in hypertensive patients with chronic renal failure antihypertensive treatment should be initiated with a drug that inhibits the renin-angiotensin system.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics